SINGLE ARMED OBSERVATIONAL DATA TO CLOSING THE GAP IN OTHERWISE DISCONNECTED EVIDENCE NETWORKS
Author(s)
Schmitz S1, Maguire A2, Morris J3, Walsh C4
1Luxembourg Institute of Health, Strassen, Luxembourg, 2Trinity College Dublin, Dublin, Ireland, 3Cogentia Healthcare Consulting, Cambridge, UK, 4University of Limerick, Castletroy, Ireland
OBJECTIVES: Bayesian network meta-analysis (NMA) allows for the estimation of relative treatment effects in a connected evidence network. We propose the use of single armed observational data to enrich the evidence base where RCT data alone does not form a connected network to allow for pairwise comparisons between treatments. The approach is presented using a case study in relapsed or refractory multiple myeloma (rrMM). METHODS: A systematic literature review of RCT evidence reveals two disconnected evidence networks. Non-comparative observational studies are matched based on study level covariates to bridge separate networks. Since such methods are prone to bias, we capture the additional uncertainty to reduce the risk of over-confident interpretation of results. Uncertainty is captured by exploring a range of possible matches to bridge the networks. RESULTS: CONCLUSIONS: The analysis illustrates how observational evidence can be used to bridge the gaps in existing RCT evidence; allowing for the indirect comparison of a large number of treatments which cannot be achieved using standard NMA methods. We stress the importance of incorporating additional uncertainty to avoid interpretation of results as if obtained from clinical trials. Appropriate communication of uncertainty is an advantage, compared to a naive assumption of equal efficacy between certain interventions, which has been done in the past.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PRM147
Topic
Methodological & Statistical Research
Topic Subcategory
Confounding, Selection Bias Correction, Causal Inference, Modeling and simulation
Disease
Oncology